21 news items
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
SNGX
24 May 24
in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
SNGX
23 May 24
in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively affect its
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
SNGX
21 May 24
, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
SNGX
21 May 24
in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively affect its business
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
SNGX
20 May 24
financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state
er8g6bkelivdktweyzjd b8z58nxwriqz63
SNGX
16 May 24
financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state
qbglgb8dc8 vel
SNGX
10 May 24
, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice
zzwwolofcisq
SNGX
6 May 24
care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively affect its business
fv4zy96tyspbdy vlvlfk2qnoxifuv8d9kphwgfbx71lm
SNGX
25 Apr 24
in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform
9la14fi1z62f9aiyz7mf3bemg8004vglrj7g2z
ADAP
CLDI
CLNN
19 Apr 24
4etw8 p5zrt7w
SNGX
18 Apr 24
in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives
elz6zmcu oc
BNTC
BPTH
CTXR
18 Apr 24
n6e8uyj7renbj9eoon
AFIB
DHAI
FBIO
17 Apr 24
7pnt7jcysqkvhx2pw1zjozezdv8i
LGVN
MRNS
NMRA
15 Apr 24
Leading and Lagging Sectors
Health care shares rose by 0.01
rk94ddtnoicx1iq8
ATHE
BSGM
JAGX
15 Apr 24
72bp1akg5v4
LGVN
MRNS
NMRA
15 Apr 24
Are Selling
Leading and Lagging Sectors
Health care shares jumped by 0.7
g9hxz378u7w3ryaiqrfi1u1x4s8pb55m
ALLR
ATHE
BMRA
15 Apr 24
goxc7cze681 ak1tl733kmu3iayb
SNGX
15 Apr 24
and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal
db059q1jk3anqk5czvm0ufucljv72umkq5w452n2sjot9kqrrieauf7fw9i
SNGX
11 Apr 24
with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations
a7py7uiqv1od0f5sk12xof326k7
SNGX
3 Apr 24
in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform